Breast Cancer Molecular Diagnostics Market - Global Outlook and Forecast 2021-2027

April 2021 | 104 pages | ID: BCA804D3C66CEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Breast Cancer Molecular Diagnostics in Global, including the following market information:

Global Breast Cancer Molecular Diagnostics Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Breast Cancer Molecular Diagnostics market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Breast Cancer Molecular Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Breast Cancer Molecular Diagnostics Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Breast Cancer Molecular Diagnostics Market Segment Percentages, By Type, 2020 (%)

• PCR
• FISH
• DNA Sequencing
• Gene Chip

China Breast Cancer Molecular Diagnostics Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Breast Cancer Molecular Diagnostics Market Segment Percentages, By Application, 2020 (%)

• Clinical Diagnosis
• Drug Screening
• Research

Global Breast Cancer Molecular Diagnostics Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Breast Cancer Molecular Diagnostics Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Breast Cancer Molecular Diagnostics Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Breast Cancer Molecular Diagnostics Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

• Roche
• Qiagen
• Illumina
• Abbott
• Oncotypeiq
• BD
• Tellgen
• Genetech
• Gpmedical
• Zeesan
• Sansure

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Breast Cancer Molecular Diagnostics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Breast Cancer Molecular Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL BREAST CANCER MOLECULAR DIAGNOSTICS OVERALL MARKET SIZE

2.1 Global Breast Cancer Molecular Diagnostics Market Size: 2021 VS 2027
2.2 Global Breast Cancer Molecular Diagnostics Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Breast Cancer Molecular Diagnostics Players in Global Market
3.2 Top Global Breast Cancer Molecular Diagnostics Companies Ranked by Revenue
3.3 Global Breast Cancer Molecular Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Breast Cancer Molecular Diagnostics Companies in Global Market, by Revenue in 2020
3.5 Global Companies Breast Cancer Molecular Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Breast Cancer Molecular Diagnostics Players in Global Market
  3.6.1 List of Global Tier 1 Breast Cancer Molecular Diagnostics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Breast Cancer Molecular Diagnostics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Breast Cancer Molecular Diagnostics Market Size Markets, 2021 & 2027
  4.1.2 PCR
  4.1.3 FISH
  4.1.4 DNA Sequencing
  4.1.5 Gene Chip
4.2 By Type - Global Breast Cancer Molecular Diagnostics Revenue & Forecasts
  4.2.1 By Type - Global Breast Cancer Molecular Diagnostics Revenue, 2016-2021
  4.2.2 By Type - Global Breast Cancer Molecular Diagnostics Revenue, 2022-2027
  4.2.3 By Type - Global Breast Cancer Molecular Diagnostics Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Breast Cancer Molecular Diagnostics Market Size, 2021 & 2027
  5.1.2 Clinical Diagnosis
  5.1.3 Drug Screening
  5.1.4 Research
5.2 By Application - Global Breast Cancer Molecular Diagnostics Revenue & Forecasts
  5.2.1 By Application - Global Breast Cancer Molecular Diagnostics Revenue, 2016-2021
  5.2.2 By Application - Global Breast Cancer Molecular Diagnostics Revenue, 2022-2027
  5.2.3 By Application - Global Breast Cancer Molecular Diagnostics Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Breast Cancer Molecular Diagnostics Market Size, 2021 & 2027
6.2 By Region - Global Breast Cancer Molecular Diagnostics Revenue & Forecasts
  6.2.1 By Region - Global Breast Cancer Molecular Diagnostics Revenue, 2016-2021
  6.2.2 By Region - Global Breast Cancer Molecular Diagnostics Revenue, 2022-2027
  6.2.3 By Region - Global Breast Cancer Molecular Diagnostics Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Breast Cancer Molecular Diagnostics Revenue, 2016-2027
  6.3.2 US Breast Cancer Molecular Diagnostics Market Size, 2016-2027
  6.3.3 Canada Breast Cancer Molecular Diagnostics Market Size, 2016-2027
  6.3.4 Mexico Breast Cancer Molecular Diagnostics Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Breast Cancer Molecular Diagnostics Revenue, 2016-2027
  6.4.2 Germany Breast Cancer Molecular Diagnostics Market Size, 2016-2027
  6.4.3 France Breast Cancer Molecular Diagnostics Market Size, 2016-2027
  6.4.4 U.K. Breast Cancer Molecular Diagnostics Market Size, 2016-2027
  6.4.5 Italy Breast Cancer Molecular Diagnostics Market Size, 2016-2027
  6.4.6 Russia Breast Cancer Molecular Diagnostics Market Size, 2016-2027
  6.4.7 Nordic Countries Breast Cancer Molecular Diagnostics Market Size, 2016-2027
  6.4.8 Benelux Breast Cancer Molecular Diagnostics Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Breast Cancer Molecular Diagnostics Revenue, 2016-2027
  6.5.2 China Breast Cancer Molecular Diagnostics Market Size, 2016-2027
  6.5.3 Japan Breast Cancer Molecular Diagnostics Market Size, 2016-2027
  6.5.4 South Korea Breast Cancer Molecular Diagnostics Market Size, 2016-2027
  6.5.5 Southeast Asia Breast Cancer Molecular Diagnostics Market Size, 2016-2027
  6.5.6 India Breast Cancer Molecular Diagnostics Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Breast Cancer Molecular Diagnostics Revenue, 2016-2027
  6.6.2 Brazil Breast Cancer Molecular Diagnostics Market Size, 2016-2027
  6.6.3 Argentina Breast Cancer Molecular Diagnostics Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Breast Cancer Molecular Diagnostics Revenue, 2016-2027
  6.7.2 Turkey Breast Cancer Molecular Diagnostics Market Size, 2016-2027
  6.7.3 Israel Breast Cancer Molecular Diagnostics Market Size, 2016-2027
  6.7.4 Saudi Arabia Breast Cancer Molecular Diagnostics Market Size, 2016-2027
  6.7.5 UAE Breast Cancer Molecular Diagnostics Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Roche
  7.1.1 Roche Corporate Summary
  7.1.2 Roche Business Overview
  7.1.3 Roche Breast Cancer Molecular Diagnostics Major Product Offerings
  7.1.4 Roche Breast Cancer Molecular Diagnostics Revenue in Global (2016-2021)
  7.1.5 Roche Key News
7.2 Qiagen
  7.2.1 Qiagen Corporate Summary
  7.2.2 Qiagen Business Overview
  7.2.3 Qiagen Breast Cancer Molecular Diagnostics Major Product Offerings
  7.2.4 Qiagen Breast Cancer Molecular Diagnostics Revenue in Global (2016-2021)
  7.2.5 Qiagen Key News
7.3 Illumina
  7.3.1 Illumina Corporate Summary
  7.3.2 Illumina Business Overview
  7.3.3 Illumina Breast Cancer Molecular Diagnostics Major Product Offerings
  7.3.4 Illumina Breast Cancer Molecular Diagnostics Revenue in Global (2016-2021)
  7.3.5 Illumina Key News
7.4 Abbott
  7.4.1 Abbott Corporate Summary
  7.4.2 Abbott Business Overview
  7.4.3 Abbott Breast Cancer Molecular Diagnostics Major Product Offerings
  7.4.4 Abbott Breast Cancer Molecular Diagnostics Revenue in Global (2016-2021)
  7.4.5 Abbott Key News
7.5 Oncotypeiq
  7.5.1 Oncotypeiq Corporate Summary
  7.5.2 Oncotypeiq Business Overview
  7.5.3 Oncotypeiq Breast Cancer Molecular Diagnostics Major Product Offerings
  7.5.4 Oncotypeiq Breast Cancer Molecular Diagnostics Revenue in Global (2016-2021)
  7.5.5 Oncotypeiq Key News
7.6 BD
  7.6.1 BD Corporate Summary
  7.6.2 BD Business Overview
  7.6.3 BD Breast Cancer Molecular Diagnostics Major Product Offerings
  7.6.4 BD Breast Cancer Molecular Diagnostics Revenue in Global (2016-2021)
  7.6.5 BD Key News
7.7 Tellgen
  7.7.1 Tellgen Corporate Summary
  7.7.2 Tellgen Business Overview
  7.7.3 Tellgen Breast Cancer Molecular Diagnostics Major Product Offerings
  7.4.4 Tellgen Breast Cancer Molecular Diagnostics Revenue in Global (2016-2021)
  7.7.5 Tellgen Key News
7.8 Genetech
  7.8.1 Genetech Corporate Summary
  7.8.2 Genetech Business Overview
  7.8.3 Genetech Breast Cancer Molecular Diagnostics Major Product Offerings
  7.8.4 Genetech Breast Cancer Molecular Diagnostics Revenue in Global (2016-2021)
  7.8.5 Genetech Key News
7.9 Gpmedical
  7.9.1 Gpmedical Corporate Summary
  7.9.2 Gpmedical Business Overview
  7.9.3 Gpmedical Breast Cancer Molecular Diagnostics Major Product Offerings
  7.9.4 Gpmedical Breast Cancer Molecular Diagnostics Revenue in Global (2016-2021)
  7.9.5 Gpmedical Key News
7.10 Zeesan
  7.10.1 Zeesan Corporate Summary
  7.10.2 Zeesan Business Overview
  7.10.3 Zeesan Breast Cancer Molecular Diagnostics Major Product Offerings
  7.10.4 Zeesan Breast Cancer Molecular Diagnostics Revenue in Global (2016-2021)
  7.10.5 Zeesan Key News
7.11 Sansure
  7.11.1 Sansure Corporate Summary
  7.11.2 Sansure Business Overview
  7.11.3 Sansure Breast Cancer Molecular Diagnostics Major Product Offerings
  7.11.4 Sansure Breast Cancer Molecular Diagnostics Revenue in Global (2016-2021)
  7.11.5 Sansure Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Breast Cancer Molecular Diagnostics Market Opportunities & Trends in Global Market
Table 2. Breast Cancer Molecular Diagnostics Market Drivers in Global Market
Table 3. Breast Cancer Molecular Diagnostics Market Restraints in Global Market
Table 4. Key Players of Breast Cancer Molecular Diagnostics in Global Market
Table 5. Top Breast Cancer Molecular Diagnostics Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Breast Cancer Molecular Diagnostics Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Breast Cancer Molecular Diagnostics Revenue Share by Companies, 2016-2021
Table 8. Global Companies Breast Cancer Molecular Diagnostics Product Type
Table 9. List of Global Tier 1 Breast Cancer Molecular Diagnostics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Breast Cancer Molecular Diagnostics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Breast Cancer Molecular Diagnostics Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Breast Cancer Molecular Diagnostics Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Breast Cancer Molecular Diagnostics Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Breast Cancer Molecular Diagnostics Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Breast Cancer Molecular Diagnostics Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Breast Cancer Molecular Diagnostics Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Breast Cancer Molecular Diagnostics Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Breast Cancer Molecular Diagnostics Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Breast Cancer Molecular Diagnostics Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Breast Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Breast Cancer Molecular Diagnostics Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Breast Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Breast Cancer Molecular Diagnostics Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Breast Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Breast Cancer Molecular Diagnostics Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Breast Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Breast Cancer Molecular Diagnostics Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Breast Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Breast Cancer Molecular Diagnostics Revenue, (US$, Mn), 2022-2027
Table 30. Roche Corporate Summary
Table 31. Roche Breast Cancer Molecular Diagnostics Product Offerings
Table 32. Roche Breast Cancer Molecular Diagnostics Revenue (US$, Mn), (2016-2021)
Table 33. Qiagen Corporate Summary
Table 34. Qiagen Breast Cancer Molecular Diagnostics Product Offerings
Table 35. Qiagen Breast Cancer Molecular Diagnostics Revenue (US$, Mn), (2016-2021)
Table 36. Illumina Corporate Summary
Table 37. Illumina Breast Cancer Molecular Diagnostics Product Offerings
Table 38. Illumina Breast Cancer Molecular Diagnostics Revenue (US$, Mn), (2016-2021)
Table 39. Abbott Corporate Summary
Table 40. Abbott Breast Cancer Molecular Diagnostics Product Offerings
Table 41. Abbott Breast Cancer Molecular Diagnostics Revenue (US$, Mn), (2016-2021)
Table 42. Oncotypeiq Corporate Summary
Table 43. Oncotypeiq Breast Cancer Molecular Diagnostics Product Offerings
Table 44. Oncotypeiq Breast Cancer Molecular Diagnostics Revenue (US$, Mn), (2016-2021)
Table 45. BD Corporate Summary
Table 46. BD Breast Cancer Molecular Diagnostics Product Offerings
Table 47. BD Breast Cancer Molecular Diagnostics Revenue (US$, Mn), (2016-2021)
Table 48. Tellgen Corporate Summary
Table 49. Tellgen Breast Cancer Molecular Diagnostics Product Offerings
Table 50. Tellgen Breast Cancer Molecular Diagnostics Revenue (US$, Mn), (2016-2021)
Table 51. Genetech Corporate Summary
Table 52. Genetech Breast Cancer Molecular Diagnostics Product Offerings
Table 53. Genetech Breast Cancer Molecular Diagnostics Revenue (US$, Mn), (2016-2021)
Table 54. Gpmedical Corporate Summary
Table 55. Gpmedical Breast Cancer Molecular Diagnostics Product Offerings
Table 56. Gpmedical Breast Cancer Molecular Diagnostics Revenue (US$, Mn), (2016-2021)
Table 57. Zeesan Corporate Summary
Table 58. Zeesan Breast Cancer Molecular Diagnostics Product Offerings
Table 59. Zeesan Breast Cancer Molecular Diagnostics Revenue (US$, Mn), (2016-2021)
Table 60. Sansure Corporate Summary
Table 61. Sansure Breast Cancer Molecular Diagnostics Product Offerings
Table 62. Sansure Breast Cancer Molecular Diagnostics Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. Breast Cancer Molecular Diagnostics Segment by Type
Figure 2. Breast Cancer Molecular Diagnostics Segment by Application
Figure 3. Global Breast Cancer Molecular Diagnostics Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Breast Cancer Molecular Diagnostics Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Breast Cancer Molecular Diagnostics Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Breast Cancer Molecular Diagnostics Revenue in 2020
Figure 8. By Type - Global Breast Cancer Molecular Diagnostics Revenue Market Share, 2016-2027
Figure 9. By Application - Global Breast Cancer Molecular Diagnostics Revenue Market Share, 2016-2027
Figure 10. By Region - Global Breast Cancer Molecular Diagnostics Revenue Market Share, 2016-2027
Figure 11. By Country - North America Breast Cancer Molecular Diagnostics Revenue Market Share, 2016-2027
Figure 12. US Breast Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Breast Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Breast Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Breast Cancer Molecular Diagnostics Revenue Market Share, 2016-2027
Figure 16. Germany Breast Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 17. France Breast Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Breast Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Breast Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Breast Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Breast Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Breast Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Breast Cancer Molecular Diagnostics Revenue Market Share, 2016-2027
Figure 24. China Breast Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Breast Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Breast Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Breast Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 28. India Breast Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Breast Cancer Molecular Diagnostics Revenue Market Share, 2016-2027
Figure 30. Brazil Breast Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Breast Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Breast Cancer Molecular Diagnostics Revenue Market Share, 2016-2027
Figure 33. Turkey Breast Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Breast Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Breast Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Breast Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 37. Roche Breast Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Qiagen Breast Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Illumina Breast Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Abbott Breast Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Oncotypeiq Breast Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. BD Breast Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Tellgen Breast Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Genetech Breast Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Gpmedical Breast Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Zeesan Breast Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)